Corcept Therapeutics, Inc. (NASDAQ:CORT)

CAPS Rating: 2 out of 5

A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.

Recs

0
Player Avatar bassettt (66.63) Submitted: 7/1/2011 11:44:33 PM : Underperform Start Price: $3.92 CORT Score: -4.32

This stock may be a worth less than 50 cents in a year. The drug the FDA is currently reviewing, Corlux, has the same active ingredient as the pill that is taken to eliminate early pregnancy. I don't see the FDA allowing such a drug to be distributed when Corlux would only benefit about 5-10 thousand people anyway. The rest of their pipeline is dependent on the same active ingredient.

Featured Broker Partners


Advertisement